Page last updated: 2024-08-22

trolamine salicylate and Infections, Coronavirus

trolamine salicylate has been researched along with Infections, Coronavirus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Balduzzi, S; Bellis, E; Delvino, P; Montecucco, C; Monti, S; Quadrelli, VS1
Joob, B; Wiwanitkit, V1
Caporali, R; Cimaz, R; Costi, S1
Caporali, R; Del Papa, N; Minniti, A; Pignataro, F; Sambataro, G1

Other Studies

4 other study(ies) available for trolamine salicylate and Infections, Coronavirus

ArticleYear
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:5

    Topics: Aged; Antirheumatic Agents; Arthritis; Betacoronavirus; Chronic Disease; Coronavirus Infections; COVID-19; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:6

    Topics: Antirheumatic Agents; Arthritis; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2

2020
Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy.
    Paediatric drugs, 2020, Volume: 22, Issue:3

    Topics: Arthritis; Betacoronavirus; Child; Coronavirus Infections; COVID-19; Humans; Italy; Pandemics; Pneumonia, Viral; Rheumatology; SARS-CoV-2

2020
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
    Autoimmunity reviews, 2020, Volume: 19, Issue:7

    Topics: Arthritis; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Scleroderma, Systemic

2020